Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -521,960 | -615,117 | 515,837 | 528,584 | -298,665 |
| Depreciation Amortization | 19,956 | 10,745 | -2,160 | 5,567 | 7,822 |
| Income taxes - deferred | -2,949 | -1,063 | -15,186 | 15,186 | -52 |
| Accounts receivable | -6,513 | -565 | 770,038 | -773,079 | N/A |
| Accounts payable and accrued liabilities | -988 | 732 | 797 | -171 | -790 |
| Other Working Capital | -84,007 | -304,591 | 665,367 | -628,394 | 29,522 |
| Other Operating Activity | 150,109 | 131,074 | -271,440 | 804,718 | 71,222 |
| Operating Cash Flow | $-446,352 | $-778,785 | $1,663,253 | $-47,589 | $-190,941 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 503,296 | 186,202 | -1,125,455 | -118,997 | -3,493 |
| PPE Investments | -3,929 | -21,573 | -68,006 | -21,817 | -6,369 |
| Investing Cash Flow | $499,367 | $164,629 | $-1,193,461 | $-140,814 | $-9,862 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -165 | -287 | -260 | -259 | -250 |
| Common Stock Issued | 4,553 | 7,767 | 36,218 | 100,590 | 533,972 |
| Other Financing Activity | 0 | 0 | -1,197 | 0 | -4,248 |
| Financing Cash Flow | $4,388 | $7,480 | $34,761 | $100,331 | $529,474 |
| Beginning Cash Position | 261,292 | 867,968 | 363,415 | 451,487 | 122,816 |
| End Cash Position | 318,695 | 261,292 | 867,968 | 363,415 | 451,487 |
| Net Cash Flow | $57,403 | $-606,676 | $504,553 | $-88,072 | $328,671 |
| Free Cash Flow | |||||
| Operating Cash Flow | -446,352 | -778,785 | 1,663,253 | -47,589 | -190,941 |
| Capital Expenditure | -7,301 | -21,573 | -68,006 | -21,817 | -6,549 |
| Free Cash Flow | -453,653 | -800,358 | 1,595,247 | -69,406 | -197,490 |